No abstract available
Keywords:
PARP inhibitors; metastatic castration-resistant prostate cancer; niraparib; olaparib; prostate cancer; rucaparib; talazoparib.
Publication types
-
Editorial
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Humans
-
Male
-
Patient Selection*
-
Poly(ADP-ribose) Polymerase Inhibitors / administration & dosage
-
Poly(ADP-ribose) Polymerase Inhibitors / pharmacology*
-
Poly(ADP-ribose) Polymerases / metabolism
-
Prostatic Neoplasms / drug therapy*
-
Prostatic Neoplasms / pathology
Substances
-
Poly(ADP-ribose) Polymerase Inhibitors
-
Poly(ADP-ribose) Polymerases